Renalytix plc American Depositary Shares
N/A
USD
N/A
N/A
...
Chart
Financials
Description
RNLX Company Description
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
RNLX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view RNLX Smart Score
Score Breakdown
RNLX Company Description
Show More
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of RNLX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by RNLX's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of RNLX in WallStreetBets Daily Discussion
RNLX News
Recent insights relating to RNLX
CNBC Recommendations
Recent picks made for RNLX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in RNLX
Corporate Flights
Flights by private jets registered to RNLX
Our Analysis